Max Healthcare Institute Ltd Analyst Rating
based on 19 analysts
63.16%
Buy
15.79%
Hold
21.05%
Sell
Based on 19 analysts offering long term price targets for Max Healthcare Institute Ltd. An average target of ₹938.32
Source: S&P Global Market Intelligence
Max Healthcare Institute Ltd Share analysis
Max Healthcare Institute Ltd price forecast by 19 analysts
Downside of
High
₹1240
Target
₹938.32
Low
₹560
Max Healthcare Institute Ltd target price ₹938.32, a slight downside of -0.16% compared to current price of ₹939.8. According to 19 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Max Healthcare Institute Ltd revenue growth forecast
Expected growth rate Q1, FY2026:78.79%
Forecast
Actual
Including amortisation and stock based compensations
Max Healthcare Institute Ltd EPS growth forecast
EPS estimate Q1, FY2026:81.25%
Forecast
Actual
Source: S&P Global Market Intelligence
Max Healthcare Institute Ltd Performance
Day's Low
Day's High
₹936₹956.6552 Week's Low
52 Week's High
₹538.65₹1,118
| Returns % | |
| 1 Month Return | + 2.85 % |
| 3 Month Return | + 4.36 % |
| 1 Year Return | + 61.78 % |
| Market Stats | |
| Previous Close | ₹952.35 |
| Open | ₹954.95 |
| Volume | 5.12L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹92,581.00Cr |
Max Healthcare Institute Ltd Key Statistics
| P/E Ratio | 86.62 |
| PEG Ratio | -71.58 |
| Market Cap | ₹92,581.00 Cr |
| P/B Ratio | 10.38 |
| EPS | 10.88 |
| Dividend Yield | 0.18 |
| Sector | Healthcare |
| ROE | 9.34 |
Max Healthcare Institute Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹92,581.00 Cr | 148.2% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹46,384.63 Cr | 70.44% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹1,00,002.95 Cr | 76.21% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
| BUY | ₹25,008.65 Cr | 82.6% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹21,657.52 Cr | 35.05% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Max Healthcare Institute Ltd Mutual Fund Holdings
About Max Healthcare Institute Ltd
Max Healthcare Institute Ltd is one of the top healthcare providers in India, offering a wide range of products and services. Its top products include diagnostic services, medical imaging, laboratory testing, and surgical services. The company also offers a range of popular brands such as Max Super Specialty Hospital, Max Multi Specialty Centre, Max Smart Super Specialty Hospital, and Max Healthcare.
Share Price: ₹939.80 per share as on 11 Oct, 2024 04:01 PM
Market Capitalisation: ₹92,581.00Cr as of today
Revenue: ₹1,542.95Cr as on June 2024 (Q2 24)
Net Profit: ₹236.27Cr as on June 2024 (Q2 24)
Listing date: 20 Aug, 2020
Chairperson Name: Abhay Soi
| Organisation | Max Healthcare Institute Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Max Healthcare Institute Ltd
Max Healthcare Sees Significant Stock Gains in 2024 - 01 Oct, 2024
Max Healthcare Institute Ltd. has experienced a 43% increase in stock value in 2024, indicating robust growth in the healthcare industry. Patients are willing to pay more for robotic surgeries, suggesting a shift towards advanced medical technologies.
Max Healthcare Acquires Majority Stake in Jaypee Healthcare - 27 Sep, 2024
Max Healthcare is set to acquire a 64% stake in Jaypee Healthcare for Rs 398 crore, enhancing its footprint in the National Capital Region. The acquisition follows a settlement agreement and awaits certain conditions. Despite the acquisition news, Max Healthcare's share price fell by 1.4% on September 27, 2024.
Max Healthcare Announces Director Cessation - 26 Sep, 2024
Max Healthcare Institute announced the cessation of Kummamuri Narasimha Murthy as an Independent Director, effective September 25, 2024, after completing his second consecutive term.
Max Healthcare Shares Surge Amid Strong Growth Outlook - 25 Sep, 2024
Max Healthcare Institute's shares rose over 23% this month, surpassing Rs 1 lakh crore market cap. The growth is driven by strong sector outlook and expansion plans, including a recent acquisition of a 64% stake in Jaypee Healthcare.
Max Healthcare Shares Surge Amid Strong Performance - 24 Sep, 2024
Max Healthcare shares rose 4.32% to Rs 1099.65, reflecting a 102.42% increase over the past year. The company reported Q1 sales of Rs 1577.63 crore, up 7.46% quarter-on-quarter and 18.95% year-on-year, with a net profit of Rs 236.27 crore. Promoters hold 23.74% stake, while FIIs own 56.99%. The MACD indicates a bullish trend.
Max Healthcare Expands Bed Capacity Significantly - 23 Sep, 2024
Max Healthcare plans to add 3,500 beds over four years, bolstered by recent acquisitions. Motilal Oswal sets a target price of Rs 1,240, reiterating a BUY rating.
Max Healthcare Expands Operations and Declares Dividend - 20 Sep, 2024
Max Healthcare Institute announces a final dividend and outlines ambitious expansion plans, including acquiring Jaypee Healthcare and adding 3,500 beds across India.
Max Healthcare Reports Strong Growth and Expansion Plans - 19 Sep, 2024
Max Healthcare is set to double its bed capacity in 4-5 years, with Q1 FY25 net revenues at Rs 1,935 crore, marking 19% YoY growth. The company continues to deliver impressive operating metrics and has recently acquired Jaypee Healthcare, despite trading at high multiples.
Max Healthcare Acquires Controlling Stake in Jaypee Healthcare - 17 Sep, 2024
Max Healthcare Institute announced the acquisition of a controlling stake in Jaypee Healthcare for Rs 1,660 crore, adding 700 beds and enhancing its capabilities. However, increased operating expenses and competition from Medanta's new facility may impact future performance.
Max Healthcare Acquires Majority Stake in Jaypee Healthcare - 16 Sep, 2024
Max Healthcare Institute has entered a strategic collaboration to acquire a 64% stake in Jaypee Healthcare for Rs 1,660 crore, enhancing its presence in the NCR. The deal includes plans to settle JHL's debts and options for future stake acquisition.
Max Healthcare Acquires Stake in Jaypee Healthcare - 14 Sep, 2024
Max Healthcare is set to acquire a 64% stake in Jaypee Healthcare for ₹1,660 crore, strengthening its foothold in the NCR region. The deal includes debt arrangements for Jaypee's creditors and is expected to close within 30 days.
Max Healthcare Acquires Controlling Stake in Jaypee Healthcare - 13 Sep, 2024
Max Healthcare Institute has entered a strategic collaboration to acquire a 64% stake in Jaypee Healthcare for Rs 1,660 crore, enhancing its presence in the NCR region. The acquisition includes the flagship 500-bed Jaypee Hospital in Noida, with plans for future expansion.
Max Healthcare Subsidiary Approves Voluntary Liquidation - 11 Sep, 2024
The Board of Directors of ET Planners Private Limited, a wholly-owned subsidiary of Max Healthcare, has approved voluntary liquidation to consolidate its business with Alps Hospital Limited.
Max Healthcare Expected to Grow Significantly - 04 Sep, 2024
Max Healthcare is projected to achieve a 2.5x stock growth in five years, with a 20% EBITDA CAGR from FY24 to FY30. However, risks like construction delays and overpriced acquisitions are noted.
Insights on Max Healthcare Institute Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 1.38K Cr → 1.57K Cr (in ₹), with an average increase of 6.4% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MAXHEALTH has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
- POSITIVE IMPACT
Price Rise
In the last 1 month, MAXHEALTH stock has moved up by 2.9%
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 78.5% return, outperforming this stock by 16.8%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 12.33% to 12.19% in Jun 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 23.75% to 23.74% in Jun 2024 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 57.33% to 56.98% in Jun 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 3.96% to 3.91% in Jun 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 289.34 Cr → 236.27 Cr (in ₹), with an average decrease of 9.6% per quarter
Max Healthcare Institute Ltd Financials
Index Inclusions
Max Healthcare Institute Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 23.74% | ||
| Foreign Institutions | 56.98% | ||
| Mutual Funds | 12.19% | ||
| Retail Investors | 3.91% | ||
| Others | 3.18% | 20.89 |
Max Healthcare Institute Ltd Key Indicators
Max Healthcare Institute Ltd Valuation
Max Healthcare Institute Ltd in the last 5 years
Lowest (-108.44x)
June 23, 2021
Today (86.62x)
October 11, 2024
Industry (95.58x)
October 11, 2024
Highest (114.93x)
September 16, 2021
Max Healthcare Institute Ltd Earnings and Dividends
Max Healthcare Institute Ltd Earnings Results
Max Healthcare Institute Ltd’s net profit fell -1.59% since last year same period to ₹236.27Cr in the Q1 2024-2025. On a quarterly growth basis, Max Healthcare Institute Ltd has generated -6.07% fall in its net profits since last 3-months.
Read More about Earnings ResultsMax Healthcare Institute Ltd Dividends May,2024
In the quarter ending March 2024, Max Healthcare Institute Ltd has declared dividend of ₹1.50 - translating a dividend yield of 0.16%.
Read More about Dividends
Max Healthcare Institute Ltd Technicals Summary
Bearish
Neutral
Bullish
Max Healthcare Institute Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Max Healthcare Institute Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Max Healthcare Institute Ltd shares.
Max Healthcare Institute Ltd (MAXHEALTH) share price today is ₹939.8
Max Healthcare Institute Ltd is listed on NSE
Max Healthcare Institute Ltd is listed on BSE
- Today’s highest price of Max Healthcare Institute Ltd is ₹956.65.
- Today’s lowest price of Max Healthcare Institute Ltd is ₹936.
PE Ratio of Max Healthcare Institute Ltd is 86.62
PE ratio = Max Healthcare Institute Ltd Market price per share / Max Healthcare Institute Ltd Earnings per share
Today’s traded volume of Max Healthcare Institute Ltd(MAXHEALTH) is 5.12L.
Today’s market capitalisation of Max Healthcare Institute Ltd(MAXHEALTH) is ₹92581Cr.
| Max Healthcare Institute Ltd(MAXHEALTH | Price |
|---|---|
52 Week High | ₹1118 |
52 Week Low | ₹538.65 |
Max Healthcare Institute Ltd(MAXHEALTH) share price is ₹939.8. It is down -15.94% from its 52 Week High price of ₹1118
Max Healthcare Institute Ltd(MAXHEALTH) share price is ₹939.8. It is up 74.47% from its 52 Week Low price of ₹538.65
| Max Healthcare Institute Ltd(MAXHEALTH | Returns |
|---|---|
1 Day Returns | -12.55% |
1 Month Returns | 2.85% |
3 Month Returns | 4.36% |
1 Year Returns | 61.78% |